TARDBP and frontotemporal dementia: Recently, it was shown that inhibition of CK1 but not TTBK1/2 could be modified by CHMP2B, a protein associated with ALS and FTD, thus causing decreased TDP-43 phosphorylation and neuroprotection [71].